John Joseph Berrios - 06 Aug 2026 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Reporting relationship: Chief Commercial Officer
Issuer ticker: GPCR
Reported as of: 06 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2026, 16:08:40 UTC
Source filing: View source filing
Reporting owner signature: /s/ Jun Yoon, Attorney-in-Fact

Key filing fact

John Joseph Berrios filed Form 4 for Structure Therapeutics Inc. (GPCR) on 07 Aug 2026.

Key facts

This page summarizes John Joseph Berrios's Form 4 filing for Structure Therapeutics Inc. (GPCR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Aug 2026, 16:08.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002148420 Primary reporting owner

Berrios John Joseph

Relationship: Chief Commercial Officer
Address: C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO
Signature: /s/ Jun Yoon, Attorney-in-Fact
Signature date: 07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GPCR transaction

Ordinary Shares

Award

Transaction value
Shares: +140,766
Change %
Price: $0.000000^*
Shares after: 140,766
Date: 06 Aug 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GPCR transaction Derivative

Share option (right to buy)

Award

Transaction value
Shares: +174,612
Change %
Price: $0.000000^*
Shares after: 174,612
Date: 06 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 174,612
Exercise price: $17.54
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

Footnote F2

Represents the grant of restricted share units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of August 6, 2026, subject to Reporting Person's continued service on such dates.

Footnote F3

The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.

Footnote F4

One-fourth of the shares vest on the first anniversary of August 6, 2026, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.